Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Aristotle Small Cap Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+19.6%
YTD+4.5%
Annualized+0.0691%
Positioning StanceCONSTRUCTIVE
Market CapSmallCap
Digest Analysis
Quick Take
"Slightly lagging its benchmark due to tactical healthcare underweights. Constructive on the asset class, leveraging a bottom-up quality approach to exploit historically cheap small-cap valuations."
Executive Summary
For the fourth quarter of 2025, the Aristotle Small Cap Equity Fund (Class I-2) generated a total return of 1.96%, underperforming the 2.19% return of the Russell 2000 Index. Underperformance was driven by allocation headwinds, specifically an underweight to the high-performing healthcare sector, while security selection in industrials and information technology served as a positive offset. The fund engaged in active capital redeployment, completing nine new acquisitions (including AptarGroup, Atlantic Union Bankshares, and LKQ Corporation) and liquidating nine positions due to corporate acquisitions or deteriorating fundamentals. The manager maintains a constructive outlook on U.S. small-cap equities, citing multi-decade low valuations relative to large-caps and structural macro tailwinds like reshoring and deregulation.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
80%
CautiousHigh
High Conviction (80%)
High-conviction positioning: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Growth Outlook
80%
BearishBullish
Bullish (80%)
Market outlook remains high conviction: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Risk Appetite
50%
DefensiveAggressive
Balanced (50%)
Risk appetite posture is moderate conviction: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Capital Deployment
70%
De-riskingDeploying
Deploying (70%)
Manager actively deployed capital into high-conviction opportunities. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Forward Guidance
60%
CautiousExpansionary
Neutral (60%)
Forward guidance signal: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Language Signal
70%
BearishBullish
Bullish (70%)
Tone analysis indicates above average conviction language: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Perceived Risk
40%
Low RiskElevated
Moderate Risk (40%)
Perceived risk level is evaluated as moderate conviction. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
Opportunity density index indicates above average conviction actionable entry points. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Time Horizon
90%
Short-TermLong-Term
Decade+ (90%)
Investment time horizon reflects a high conviction orientation. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...